Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use Authorization
On Aug. 15, 2020, a saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public…
AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
Mapping tool highlights NIH-funded small business successes
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
Philips launched Rapid Equipment Deployment Kit to COVID-19 response
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
HHS announced collaboration with Aegis Sciences for high quality rapid COVID-19 RT-PCR testing
On Aug. 13, 2020, the U.S. Department of Health and Human Services (HHS) announced combined investments of $6.5…
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
FDA approved targeted treatment for rare Duchenne Muscular Dystrophy mutation
On Aug. 12, 2020, the FDA granted accelerated approval to NS Pharma’s Viltepso (viltolarsen) injection for the treatment…
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
Hologic launched validated pooling protocol for COVID-19 testing
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptimaﾮ and Panther Fusionﾮ molecular…
Bio-Techne announced new SARS-CoV-1/2 spike RBD LlaMABodyﾙ recombinant antibody that blocks viral entry
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
LabCorp to perform antibody test at no charge to accelerate COVID-19 blood plasma donation
On Aug. 11, 2020, LabCorpﾮ announced details of a no charge antibody testing program in response to federal…
Clinical trials of monoclonal antibodies to prevent COVID-19 began enrollment
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
25-year dolphin study revealed factors contributing to aging rates in long-lived mammals
On Aug. 10, 2020, Epitracker and the Translational Genomics Research Institute (TGen) announced the results from a groundbreaking,…
Vaxart announced IND filed for COVID-19 vaccine
On Aug. 10, 2020, Vaxart announced that its COVID-19 Investigational New Drug (IND) application has been filed with…
Cors Blood Registry by Generate Life Sciences partnered with Nantwest to develop COVID-19 treatment
On Aug. 10, 2020, CBRﾮ by Generate Life Sciences, the worldﾒs largest private newborn stem cell bank, and…
Humanigen expands phase III study of lenzilumab in COVID-19 to Brazil
On Aug. 10, 2020, Humanigen announced that the Brazilian regulatory agency, Anvisa, had granted permission to commence a…
IBIO-201 demonstrated ability to elicit anti-SARS-CoV-2 immune response in preclinical studies
On Aug. 10, 2020, iBio provided an update on one of its proprietary vaccine candidates being designed to…
Omeros reported recovery and durvival of all patients in study evaluating narsoplimab fortreatment of COVID-19-associated Acute Respiratory Distress Syndrome
On Aug. 10, 2020, Omeros reported the results of a compassionate-use study evaluating narsoplimab, Omerosﾒ investigational human monoclonal…
Intravacc received US NIH/NIAID contract to develop Enterovirus D68 Vaccine
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
OpGen began co-marketing COVID-19 antibody test kit
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
Pfizer announced agreement with Gilead to manufacture remdesivir for treatment of COVID-19
On Aug. 7, 2020, Pfizer announced a multi-year agreement with Gilead Sciences to manufacture and supply Gileadﾒs investigational…
HKUMed discovered that acute SARS-CoV-2 infection impairs human immune defences
On Aug. 6, 2020, researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging…
FDA approved two emergency INDs for COVID-19 outpatient therapy
On Aug. 6, 2020, Organicell Regenerative Medicine announced that the FDA had approved two outpatient Emergency Investigational New…
NIH began clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
BioNTech and Fosun Pharma announced start of clinical trial of mRNA-based COVID-19 vaccine candidate in China
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
Thermo Fisher Scientific’s COVID-19 response expand with new high-throughput automated testing solution
On Aug. 5, 2020,Thermo Fisher Scientific announced a new highly automated, real-time PCR solution designed to analyze up…
Heat Biologics highlighted Importance of T cell immunity to prevent COVID-19
On Aug. 5, 2020, Heat Biologics highlighted the importance of T cell immunity in preventing COVID-19 in a…
Johnson & Johnson announces agreement with US Government for 100 million doses of investigational COVID-19 vaccine
On Aug. 5, 2020, Johnson & Johnson announced a $1 billion agreement with the U.S. government for the…